Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection.
dc.contributor.author | Sánchez-Calvo, Juan M | |
dc.contributor.author | Alados Arboledas, Juan C | |
dc.contributor.author | Ros Vidal, Luis | |
dc.contributor.author | de Francisco, José L | |
dc.contributor.author | López Prieto, María D | |
dc.date.accessioned | 2025-01-07T12:54:01Z | |
dc.date.available | 2025-01-07T12:54:01Z | |
dc.date.issued | 2021-07-16 | |
dc.description.abstract | To compare the RT-PCR Allplex SARS-CoV-2/FluA/FluB/RSV Assay (Allplex assay) with other methods of detection of VOC B.1.1.7. Suspected and non-suspected cases of VOC B.1.1.7 were defined according to the VirSNiP assay, which detects N501Y and deletion H69-V70. For pre-screening, the Allplex™ and TaqPath assays were used. One hundred and sixteen suspected and 113 non-suspected cases were included. In the suspected cases, the Allplex assay showed N-gene dropout, or delayed Ct values of 6.27 ± 1.21 and 6.66 ± 1.41 compared with those of the RdRP and S-gene target, respectively. Agreement between the Allplex and TaqPath assays was 100% when the RdRP and S-gene targets had Ct values | |
dc.identifier.doi | 10.1016/j.diagmicrobio.2021.115491 | |
dc.identifier.essn | 1879-0070 | |
dc.identifier.pmc | PMC8282941 | |
dc.identifier.pmid | 34464903 | |
dc.identifier.pubmedURL | https://pmc.ncbi.nlm.nih.gov/articles/PMC8282941/pdf | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.diagmicrobio.2021.115491 | |
dc.identifier.uri | https://hdl.handle.net/10668/25028 | |
dc.issue.number | 4 | |
dc.journal.title | Diagnostic microbiology and infectious disease | |
dc.journal.titleabbreviation | Diagn Microbiol Infect Dis | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario de Jerez de la Frontera | |
dc.page.number | 115491 | |
dc.pubmedtype | Journal Article | |
dc.rights.accessRights | open access | |
dc.subject | 2019-nCoV RT-PCR diagnostic panel | |
dc.subject | Mutation | |
dc.subject | SARS-CoV-2 | |
dc.subject | Screening Assays | |
dc.subject | Variant | |
dc.subject | Whole-genome sequencing | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Coronavirus Nucleocapsid Proteins | |
dc.subject.mesh | Feasibility Studies | |
dc.subject.mesh | Gene Expression Regulation, Viral | |
dc.subject.mesh | Genome, Viral | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Phosphoproteins | |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Sensitivity and Specificity | |
dc.subject.mesh | Whole Genome Sequencing | |
dc.title | Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 101 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- PMC8282941.pdf
- Size:
- 626.56 KB
- Format:
- Adobe Portable Document Format